Publications by authors named "Rika Mukohara"
Article Synopsis
- A 72-year-old man with type 2 diabetes and chronic kidney disease developed hypoglycemia after starting vadadustat, which he took alongside sitagliptin and mitiglinide.
- The patient's blood glucose levels dropped significantly after 23 days of using vadadustat, leading to a blood glucose reading of 67 mg/dL.
- Discontinuing vadadustat improved his blood glucose levels, and the interaction between vadadustat and sitagliptin was classified as "Probable" due to potential renal drug interactions.
Purpose: Delayed elimination of methotrexate (MTX) has been reported to be caused by a number of factors. In order to identify these causes, we retrospectively investigated the risk factors for delayed elimination in pediatric patients who received high doses of MTX.
Subjects And Methods: The study included 69 courses of therapy involving 22 patients who received more than 1000 mg/m(2) of MTX.
Digoxin concentrations measured by three automated immunoassay systems, i.e. OPUS, TDx and IMx assays, were compared in order to evaluate precision and accuracy performance, and data compatibility.
View Article and Find Full Text PDF